Therapeutic Efficacy Evaluation of Tetrandrine with or without Radiation on Murine Colorectal Adenocarcinoma both in vitro and in Vivo with a Novel Reporter Gene System-tk-luc

碩士 === 國立陽明大學 === 放射醫學科學研究所 === 94 === AIM: To investigate the combined effect of tetrandrine and radiation on C26 colorectal adenocarcinoma cells in vitro and evaluate the efficacy of chemo-radiotherapy on C26 colorectal adenocarcinoma bearing mice which were transfected with dual tk (herpes si...

Full description

Bibliographic Details
Main Authors: Shan-Yun Cheng, 鄭善云
Other Authors: Jeng-Jong Hwang
Format: Others
Language:zh-TW
Published: 2006
Online Access:http://ndltd.ncl.edu.tw/handle/71755438193187881526
id ndltd-TW-094YM005605010
record_format oai_dc
spelling ndltd-TW-094YM0056050102015-10-13T16:31:16Z http://ndltd.ncl.edu.tw/handle/71755438193187881526 Therapeutic Efficacy Evaluation of Tetrandrine with or without Radiation on Murine Colorectal Adenocarcinoma both in vitro and in Vivo with a Novel Reporter Gene System-tk-luc Tetrandrine單獨與併用游離輻射並結合tk-luc雙報導基因系統對小鼠大腸直腸癌細胞及活體動物之療效評估 Shan-Yun Cheng 鄭善云 碩士 國立陽明大學 放射醫學科學研究所 94 AIM: To investigate the combined effect of tetrandrine and radiation on C26 colorectal adenocarcinoma cells in vitro and evaluate the efficacy of chemo-radiotherapy on C26 colorectal adenocarcinoma bearing mice which were transfected with dual tk (herpes simplex virus tupe 1 thymidine kinase, HSV1-tk) and luc (luciferase) genes through plasmid vectors. METHODS: We examined the anti-proliferative and apoptosis-inducing activities of tetrandrine with colony formation, flow cytometry, DNA fragmentation, Western blotting and caspase-3 activity assays. In this study, we also evaluated the combined effect of tetrandrine and ionizing radiation on C26/tk-luc tumor-bearing animal model. BALB/c mice were subcutaneously implanted with C26/tk-luc cells and divided into several groups: control, various concentrations of tetrandrine (intra-peritoneal injection), radiation treatment (RT) alone, and combination of tetrandrine with radiation. The therapeutic efficiency was evaluated with multimodalities of caliper, bioluminescent imaging (BLI) and gamma scintigraphy. RESULTS: Cytotoxic effect of tetrandrine on C26 cells treated for 3 hours in vitro was found (IC50~10uM). Alteration of cell morphology, caspase-3 activation, DNA fragmentation and dose-dependent induction of apoptosis were observed both in drug alone and combination groups. The tumor growth was delayed in a dose independent manner after various concentrations of tetrandrine treatment. However, the tumor growth rate was significantly inhibited by RT and combination groups, and the latter even showed the synergistic effect. Body weights of all groups showed no significant change. Both skin and hair are also normal for all groups. These results suggest that tetrandrine is not only potentially useful as a chemotherapeutic agent, but a radiosensitizer for colorectal adenocarcinoma treatment. CONCLUSIONS: 1.Tetrandrine is cytotoxic to C26 murine colorectal adenocarcinoma cells in vitro due to the induction of apoptosis mainly through the caspase-3 activation. 2.Tetrandrine sensitizes C26/tk-luc colorectal tumor to radiation with a synergistic effect. Combination therapy of TET+RT may have potential as a treatment alternative in clinic for cancer chemo-radiotherapy. 3.Non-invasive bioluminescent imaging is a useful tool for the evaluation of the therapeutic efficacy evaluation, because the same cohort of animals can be screened over times throughout the treatment without sacrifice. Jeng-Jong Hwang 黃正仲 2006 學位論文 ; thesis 61 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立陽明大學 === 放射醫學科學研究所 === 94 === AIM: To investigate the combined effect of tetrandrine and radiation on C26 colorectal adenocarcinoma cells in vitro and evaluate the efficacy of chemo-radiotherapy on C26 colorectal adenocarcinoma bearing mice which were transfected with dual tk (herpes simplex virus tupe 1 thymidine kinase, HSV1-tk) and luc (luciferase) genes through plasmid vectors. METHODS: We examined the anti-proliferative and apoptosis-inducing activities of tetrandrine with colony formation, flow cytometry, DNA fragmentation, Western blotting and caspase-3 activity assays. In this study, we also evaluated the combined effect of tetrandrine and ionizing radiation on C26/tk-luc tumor-bearing animal model. BALB/c mice were subcutaneously implanted with C26/tk-luc cells and divided into several groups: control, various concentrations of tetrandrine (intra-peritoneal injection), radiation treatment (RT) alone, and combination of tetrandrine with radiation. The therapeutic efficiency was evaluated with multimodalities of caliper, bioluminescent imaging (BLI) and gamma scintigraphy. RESULTS: Cytotoxic effect of tetrandrine on C26 cells treated for 3 hours in vitro was found (IC50~10uM). Alteration of cell morphology, caspase-3 activation, DNA fragmentation and dose-dependent induction of apoptosis were observed both in drug alone and combination groups. The tumor growth was delayed in a dose independent manner after various concentrations of tetrandrine treatment. However, the tumor growth rate was significantly inhibited by RT and combination groups, and the latter even showed the synergistic effect. Body weights of all groups showed no significant change. Both skin and hair are also normal for all groups. These results suggest that tetrandrine is not only potentially useful as a chemotherapeutic agent, but a radiosensitizer for colorectal adenocarcinoma treatment. CONCLUSIONS: 1.Tetrandrine is cytotoxic to C26 murine colorectal adenocarcinoma cells in vitro due to the induction of apoptosis mainly through the caspase-3 activation. 2.Tetrandrine sensitizes C26/tk-luc colorectal tumor to radiation with a synergistic effect. Combination therapy of TET+RT may have potential as a treatment alternative in clinic for cancer chemo-radiotherapy. 3.Non-invasive bioluminescent imaging is a useful tool for the evaluation of the therapeutic efficacy evaluation, because the same cohort of animals can be screened over times throughout the treatment without sacrifice.
author2 Jeng-Jong Hwang
author_facet Jeng-Jong Hwang
Shan-Yun Cheng
鄭善云
author Shan-Yun Cheng
鄭善云
spellingShingle Shan-Yun Cheng
鄭善云
Therapeutic Efficacy Evaluation of Tetrandrine with or without Radiation on Murine Colorectal Adenocarcinoma both in vitro and in Vivo with a Novel Reporter Gene System-tk-luc
author_sort Shan-Yun Cheng
title Therapeutic Efficacy Evaluation of Tetrandrine with or without Radiation on Murine Colorectal Adenocarcinoma both in vitro and in Vivo with a Novel Reporter Gene System-tk-luc
title_short Therapeutic Efficacy Evaluation of Tetrandrine with or without Radiation on Murine Colorectal Adenocarcinoma both in vitro and in Vivo with a Novel Reporter Gene System-tk-luc
title_full Therapeutic Efficacy Evaluation of Tetrandrine with or without Radiation on Murine Colorectal Adenocarcinoma both in vitro and in Vivo with a Novel Reporter Gene System-tk-luc
title_fullStr Therapeutic Efficacy Evaluation of Tetrandrine with or without Radiation on Murine Colorectal Adenocarcinoma both in vitro and in Vivo with a Novel Reporter Gene System-tk-luc
title_full_unstemmed Therapeutic Efficacy Evaluation of Tetrandrine with or without Radiation on Murine Colorectal Adenocarcinoma both in vitro and in Vivo with a Novel Reporter Gene System-tk-luc
title_sort therapeutic efficacy evaluation of tetrandrine with or without radiation on murine colorectal adenocarcinoma both in vitro and in vivo with a novel reporter gene system-tk-luc
publishDate 2006
url http://ndltd.ncl.edu.tw/handle/71755438193187881526
work_keys_str_mv AT shanyuncheng therapeuticefficacyevaluationoftetrandrinewithorwithoutradiationonmurinecolorectaladenocarcinomabothinvitroandinvivowithanovelreportergenesystemtkluc
AT zhèngshànyún therapeuticefficacyevaluationoftetrandrinewithorwithoutradiationonmurinecolorectaladenocarcinomabothinvitroandinvivowithanovelreportergenesystemtkluc
AT shanyuncheng tetrandrinedāndúyǔbìngyòngyóulífúshèbìngjiéhétklucshuāngbàodǎojīyīnxìtǒngduìxiǎoshǔdàchángzhíchángáixìbāojíhuótǐdòngwùzhīliáoxiàopínggū
AT zhèngshànyún tetrandrinedāndúyǔbìngyòngyóulífúshèbìngjiéhétklucshuāngbàodǎojīyīnxìtǒngduìxiǎoshǔdàchángzhíchángáixìbāojíhuótǐdòngwùzhīliáoxiàopínggū
_version_ 1717771921830969344